# A Trial to Assess the Pharmacokinetic Profile (e.g., Uptake, Distribution and Excretion of a Substance in the Body) of Nomegestrol Acetate (NOMAC), Estradiol (E2) and Estrone (E1) After Multiple and Single Dose Administration of the Combined Oral Contraception NOMAC-E2 (COMPLETED)(P05822)

> **NCT00711607** · PHASE1 · COMPLETED · sponsor: **Organon and Co** · enrollment: 25 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** nomegestrol acetate and estradiol

## Key facts

- **NCT ID:** NCT00711607
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05-01
- **Primary completion:** 2007-09-01
- **Final completion:** 2007-09-01
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2022-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00711607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00711607, "A Trial to Assess the Pharmacokinetic Profile (e.g., Uptake, Distribution and Excretion of a Substance in the Body) of Nomegestrol Acetate (NOMAC), Estradiol (E2) and Estrone (E1) After Multiple and Single Dose Administration of the Combined Oral Contraception NOMAC-E2 (COMPLETED)(P05822)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00711607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*